Publication:
The early injected genomic region determines sensitivity to Type I restriction-modification defence against Autographiviridae phages

dc.contributor.authorMartínez Cazorla, Andrea
dc.contributor.authorMartínez Jiménez, Christian José
dc.contributor.authorElío Lucas, Patrícia
dc.contributor.authorFineran, Peter C.
dc.contributor.authorJackson, Simon
dc.contributor.authorSánchez Amat, Antonio
dc.contributor.departmentGenética y Microbiología
dc.date.accessioned2026-01-12T12:51:50Z
dc.date.available2026-01-12T12:51:50Z
dc.date.copyright© The Author(s) 2025
dc.date.issued2025-10-14
dc.formatapplication/pdf
dc.format.extent10
dc.identifier.citationNucleic Acids Research, Volume, 2025, Vol. 53, Issue 18, gkaf926,
dc.identifier.doihttps://doi.org/10.1093/nar/gkaf926
dc.identifier.eissn1362-4962
dc.identifier.issn0305-1048
dc.identifier.urihttp://hdl.handle.net/10201/185730
dc.languageeng
dc.publisherOxford University Press
dc.relationThis research was supported by grant number PID2021-124464NB-I00, funded by the Spanish Ministerio de Ciencia e Innovación/Agencia Española de Investigación MCIN/AEI/10.13039/501100011033 and by European Regional Development Funds ‘ERDF A way of making Europe’. A.M.-C. and C.M.-J. were supported by pre-doctoral contracts by the University of Murcia. S.A.J. and P.C.F. were supported by Bioprotection Aotearoa (Tertiary Education Commission, New Zealand). S.A.J. was supported by a Sir Charles Hercus Fellowship from the Health Research Council of New Zealand, grant number 23/228/A, and funding from the Marsden Fund, Royal Society of New Zealand Te Apārangi, grant number UOO1814. P.C.F. was supported by a James Cook Research Fellowship (RSNZ, Te Apārangi).
dc.relation.publisherversionhttps://academic.oup.com/nar/article/53/18/gkaf926/8262241
dc.relation.requireshttp://hdl.handle.net/10201/155651
dc.rightsAttribution-NonCommercial 4.0 International*
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.subject.odsNo relacionado con ningún objetivo de desarrollo sostenible
dc.titleThe early injected genomic region determines sensitivity to Type I restriction-modification defence against Autographiviridae phages
dc.typeinfo:eu-repo/semantics/article
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dspace.entity.typePublicationes
relation.isAuthorOfPublication6f914d22-ba9d-49cd-8e26-0f87c9b3898d
relation.isAuthorOfPublication66095fe4-223f-4dbc-9b73-7cade64d2e20
relation.isAuthorOfPublication15331c24-15e1-4518-824f-57238c36ed42
relation.isAuthorOfPublication.latestForDiscovery6f914d22-ba9d-49cd-8e26-0f87c9b3898d
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
NAR 2025 typeI RM.pdf
Size:
1.28 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.37 KB
Format:
Item-specific license agreed upon to submission
Description:
Collections